|  Help  |  About  |  Contact Us

Publication : Development of a functional skin matrix requires deposition of collagen V heterotrimers.

First Author  Chanut-Delalande H Year  2004
Journal  Mol Cell Biol Volume  24
Issue  13 Pages  6049-57
PubMed ID  15199158 Mgi Jnum  J:91589
Mgi Id  MGI:3047505 Doi  10.1128/MCB.24.13.6049-6057.2004
Citation  Chanut-Delalande H, et al. (2004) Development of a functional skin matrix requires deposition of collagen V heterotrimers. Mol Cell Biol 24(13):6049-57
abstractText  Collagen V is a minor component of the heterotypic I/III/V collagen fibrils and the defective product in most cases of classical Ehlers Danlos syndrome (EDS). The present study was undertaken to elucidate the impact of collagen V mutations on skin development, the most severely affected EDS tissues, using mice harboring a targeted deletion of the alpha2(V) collagen gene (Col5a2). Contrary to the original report, our studies indicate that the Col5a2 deletion (a.k.a. the pN allele) represents a functionally null mutation that affects matrix assembly through a complex sequence of events. First the mutation impairs assembly and/or secretion of the alpha1(V)(2)alpha2(V) heterotrimer with the result that the alpha1(V) homotrimer is the predominant species deposited into the matrix. Second, the alpha1(V) homotrimer is excluded from incorporation into the heterotypic collagen fibrils and this in turn severely impairs matrix organization. Third, the mutant matrix stimulates a compensatory loop by the alpha1(V) collagen gene that leads to additional deposition of alpha1(V) homotrimers. These data therefore underscore the importance of the collagen V heterotrimer in dermal fibrillogenesis. Furthermore, reduced thickness of the basement membranes underlying the epidermis and increased apoptosis of the stromal fibroblasts in pN/pN skin strongly indicate additional roles of collagen V in the development of a functional skin matrix.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

4 Bio Entities

Trail: Publication

0 Expression